Odon Lifesciences Pvt. Ltd. is a rapidly growing Oncology PCD Pharma Franchise Company in India, dedicated to manufacturing and supplying high-quality oncology and hormonal medicines. As a subsidiary of East Africa (India) Overseas, the company benefits from decades of pharmaceutical expertise and global market presence. Its modern manufacturing facility is designed specifically for oncology formulations and operates in compliance with WHO-GMP and ISO standards, ensuring world-class quality, safety, and regulatory compliance.
The company offers an extensive oncology portfolio comprising chemotherapy medicines, targeted therapies, hormone blockers, cytotoxic drugs, supportive oncology treatments, and hormonal formulations. Odon Lifesciences also provides comprehensive Oncology PCD Pharma Franchise opportunities with monopoly rights, attractive promotional materials, product training, competitive pricing, and efficient logistics support. These services enable franchise partners to establish and expand a successful oncology-focused pharmaceutical business.
Driven by innovation, research, and patient-centric healthcare, Odon Lifesciences continuously invests in advanced technologies, dedicated oncology production facilities, and stringent quality assurance systems. With a strong commitment to ethical business practices, customized manufacturing solutions, and timely product delivery, the company has established itself among the leading Oncology PCD Pharma Franchise Companies in India while expanding its presence in international pharmaceutical markets.
Odon Lifesciences follows stringent WHO-GMP and ISO-certified quality systems, ensuring every oncology medicine undergoes rigorous testing for safety, efficacy, purity, and regulatory compliance.
Odon Lifesciences follows stringent WHO-GMP and ISO-certified quality systems, ensuring every oncology medicine undergoes rigorous testing for safety, efficacy, purity, and regulatory compliance.
Odon Lifesciences follows stringent WHO-GMP and ISO-certified quality systems, ensuring every oncology medicine undergoes rigorous testing for safety, efficacy, purity, and regulatory compliance.
N/A